BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 15184071)

  • 1. Identification of two antigenic epitopes on SARS-CoV spike protein.
    Hua R; Zhou Y; Wang Y; Hua Y; Tong G
    Biochem Biophys Res Commun; 2004 Jul; 319(3):929-35. PubMed ID: 15184071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of monoclonal antibodies against SARS-CoV and identification of antigenic epitopes].
    Zhou YJ; Hua RH; Wang YF; An TQ; Liu JX; Yang JY; Hua YZ; Tong GZ
    Sheng Wu Gong Cheng Xue Bao; 2005 Mar; 21(2):211-5. PubMed ID: 16013477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and antigenic epitope mapping of immunodominant region amino residues 510 to 672 on the spike protein of the severe acute respiratory syndrome coronavirus.
    Hua RH; Wang YF; Bu ZG; Zhou YJ; Ge JY; Wang XJ; Tong GZ
    DNA Cell Biol; 2005 Aug; 24(8):503-9. PubMed ID: 16101348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design.
    He Y; Li J; Heck S; Lustigman S; Jiang S
    J Virol; 2006 Jun; 80(12):5757-67. PubMed ID: 16731915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies.
    He Y; Lu H; Siddiqui P; Zhou Y; Jiang S
    J Immunol; 2005 Apr; 174(8):4908-15. PubMed ID: 15814718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants.
    ter Meulen J; van den Brink EN; Poon LL; Marissen WE; Leung CS; Cox F; Cheung CY; Bakker AQ; Bogaards JA; van Deventer E; Preiser W; Doerr HW; Chow VT; de Kruif J; Peiris JS; Goudsmit J
    PLoS Med; 2006 Jul; 3(7):e237. PubMed ID: 16796401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic peptide studies on the severe acute respiratory syndrome (SARS) coronavirus spike glycoprotein: perspective for SARS vaccine development.
    Choy WY; Lin SG; Chan PK; Tam JS; Lo YM; Chu IM; Tsai SN; Zhong MQ; Fung KP; Waye MM; Tsui SK; Ng KO; Shan ZX; Yang M; Wu YL; Lin ZY; Ngai SM
    Clin Chem; 2004 Jun; 50(6):1036-42. PubMed ID: 15044316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology.
    Berry JD; Hay K; Rini JM; Yu M; Wang L; Plummer FA; Corbett CR; Andonov A
    MAbs; 2010; 2(1):53-66. PubMed ID: 20168090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies.
    Zhang H; Wang G; Li J; Nie Y; Shi X; Lian G; Wang W; Yin X; Zhao Y; Qu X; Ding M; Deng H
    J Virol; 2004 Jul; 78(13):6938-45. PubMed ID: 15194770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acids 1055 to 1192 in the S2 region of severe acute respiratory syndrome coronavirus S protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents.
    Keng CT; Zhang A; Shen S; Lip KM; Fielding BC; Tan TH; Chou CF; Loh CB; Wang S; Fu J; Yang X; Lim SG; Hong W; Tan YJ
    J Virol; 2005 Mar; 79(6):3289-96. PubMed ID: 15731223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus.
    van den Brink EN; Ter Meulen J; Cox F; Jongeneelen MA; Thijsse A; Throsby M; Marissen WE; Rood PM; Bakker AB; Gelderblom HR; Martina BE; Osterhaus AD; Preiser W; Doerr HW; de Kruif J; Goudsmit J
    J Virol; 2005 Feb; 79(3):1635-44. PubMed ID: 15650189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preparation and characterization of the epitopes of SARS coronavirus spike protein].
    Fang K; Zhong LS; Ma RH; Wang SC; Pan ZC; Zhang YK; He Q; Zhao YJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Nov; 23(11):1007-9. PubMed ID: 17988578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies.
    Zhou T; Wang H; Luo D; Rowe T; Wang Z; Hogan RJ; Qiu S; Bunzel RJ; Huang G; Mishra V; Voss TG; Kimberly R; Luo M
    J Virol; 2004 Jul; 78(13):7217-26. PubMed ID: 15194798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping a neutralizing epitope on the SARS coronavirus spike protein: computational prediction based on affinity-selected peptides.
    Tarnovitski N; Matthews LJ; Sui J; Gershoni JM; Marasco WA
    J Mol Biol; 2006 May; 359(1):190-201. PubMed ID: 16630634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV).
    Lai SC; Chong PC; Yeh CT; Liu LS; Jan JT; Chi HY; Liu HW; Chen A; Wang YC
    J Biomed Sci; 2005 Oct; 12(5):711-27. PubMed ID: 16132115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chicken single-chain variable fragments against the SARS-CoV spike protein.
    Lee YC; Leu SJ; Hu CJ; Shih NY; Huang IJ; Wu HH; Hsieh WS; Chiang BL; Chiu WT; Yang YY
    J Virol Methods; 2007 Dec; 146(1-2):104-11. PubMed ID: 17643500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody binding site mapping of SARS-CoV spike protein receptor-binding domain by a combination of yeast surface display and phage peptide library screening.
    Zhang X; Wang J; Wen K; Mou Z; Zou L; Che X; Ni B; Wu Y
    Viral Immunol; 2009 Dec; 22(6):407-15. PubMed ID: 19951177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: revealing the critical antigenic determinants in inactivated SARS-CoV vaccine.
    He Y; Li J; Du L; Yan X; Hu G; Zhou Y; Jiang S
    Vaccine; 2006 Jun; 24(26):5498-508. PubMed ID: 16725238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dominant antigenic epitope on SARS-CoV spike protein identified by an avian single-chain variable fragment (scFv)-expressing phage.
    Lee YC; Leu SJ; Hung HC; Wu HH; Huang IJ; Hsieh WS; Chiu WT; Hsieh MS; Cheng TF; Yang YY
    Vet Immunol Immunopathol; 2007 May; 117(1-2):75-85. PubMed ID: 17360045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Template-based coiled-coil antigens elicit neutralizing antibodies to the SARS-coronavirus.
    Tripet B; Kao DJ; Jeffers SA; Holmes KV; Hodges RS
    J Struct Biol; 2006 Aug; 155(2):176-94. PubMed ID: 16697221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.